Tag: JILL
-
Up 51% – CANSLIM Growth Portfolio Update -January 2025

The CANSLIM Growth Model Portfolio has increased by over 51% in 2023-2024, significantly surpassing its benchmark BSMAX by 21%. The portfolio, consisting of 20 stocks, uses the CANSLIM approach focused on earnings per share, return on equity, and sales growth. Recent changes included adding six stocks and removing five.
-
Up 49% – CANSLIM Growth Portfolio Update December 2024

The CANSLIM Growth Model Portfolio has risen over 49% in 2023-2024, outperforming the BSMAX benchmark by 23%. Recent updates added 2 stocks and removed 3, with 19 stocks now in the portfolio. Backtesting shows consistent outperformance across 18 of 19 years, highlighting the effectiveness of the CANSLIM strategy.
-
Up 44% – CANSLIM Growth Portfolio Update 08/23/2024

The CANSLIM Growth Model Portfolio was updated with 6 new stock additions and 7 removals, totaling 18 stocks. It has outperformed its benchmark by 18% and has recorded significant backtest outperformance. The portfolio follows the CANSLIM approach, focusing on EPS, Return on Equity, and Sales Increase. Notable active transactions and impressive performance details are also…
